Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Award
Common Stock
2026-01-06+150,000→ 1,793,068 total
Footnotes (2)
- [F1]The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Shemesh's continued service on such dates.
- [F2]Includes shares of restricted common stock.